Monoclonale antibody: Mouse anti-human complement Factor H

Scientists at the Georg-August-University produced monoclonal antibodies which react with the polymorphic variant of human complement Factor H (FH-402(His), a marker for age-related macular degeneration. These peptide-specific antibodies specifically react with the polymorphic variants of human complement Factor H (either FH-402Y or FH-402H). Therefor they can be used for the screening of individuals at risk for developing AMD, as well as for the functional characterization of complement Factor H variants. AMD is the leading cause of blindness in the elderly. Because there is the chance to treat AMD with a new drug ( anti-VEGF-antibodies) nowadays this would increase the value of a new diagnostic screening assay.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Sea slugs inspire highly stretchable biomedical sensor

USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…

Twisting and binding matter waves with photons in a cavity

Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…

Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl

New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…

Partners & Sponsors